MEGAN MCCREA: Open Payments
NPI 1548822323 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 28 payments from 10 companies in 2025. Trend: 2023 $1,111 · 2024 $1,099 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 12 | $262 |
| ABBVIE INC. | 5 | $195 |
| Janssen Biotech, Inc. | 1 | $115 |
| GENZYME CORPORATION | 1 | $105 |
| Galderma Laboratories, L.P. | 3 | $49 |
| UCB, Inc. | 2 | $41 |
| PFIZER INC. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: OPZELURA, SKYRIZI, TREMFYA, DUPIXENT, Bimzelx, NEMLUVIO, CIBINQO, RINVOQ.
Industry payments across MA — which companies pay providers there.
